Arbutus Biopharma Corporation (FRA:I9DN)
3.708
+0.198 (5.64%)
At close: Dec 4, 2025
16.82% (1Y)
| Market Cap | 730.72M |
| Revenue (ttm) | 12.45M |
| Net Income (ttm) | -36.03M |
| Shares Out | n/a |
| EPS (ttm) | -0.19 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 384 |
| Open | 3.708 |
| Previous Close | 3.510 |
| Day's Range | 3.708 - 3.708 |
| 52-Week Range | 2.546 - 4.310 |
| Beta | n/a |
| RSI | 48.65 |
| Earnings Date | Mar 5, 2026 |